Rare disease player rakes in a meaty $81M in Spain's biggest ever private biotech fundraise
Funding rounds in the United States for the life sciences industry often dwarf financing in Europe. Looks like rare disease biotech Sanifit is an anomaly …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
